» Articles » PMID: 23295419

Cross-cultural Adaptation and Validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian Population

Overview
Publisher Thieme
Specialties Neurology
Psychiatry
Date 2013 Jan 9
PMID 23295419
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Gait impairment is reported by 85% of patients with multiple sclerosis (MS) as main complaint. In 2003, Hobart et al. developed a scale for walking known as The 12-item Multiple Sclerosis Walking Scale (MSWS-12), which combines the perspectives of patients with psychometric methods.

Objective: This study aimed to cross-culturally adapt and validate the MSWS-12 for the Brazilian population with MS.

Methods: This study included 116 individuals diagnosed with MS, in accordance with McDonald's criteria. The steps of the adaptation process included translation, back-translation, review by an expert committee and pretesting. A test and retest of MSWS-12/BR was made for validation, with comparison with another scale (MSIS-29/BR) and another test (T25FW).

Results: The Brazilian version of MSWS-12/BR was shown to be similar to the original. The results indicate that MSWS-12/BR is a reliable and reproducible scale.

Conclusions: MSWS-12/BR has been adapted and validated, and it is a reliable tool for the Brazilian population.

Citing Articles

Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.

Chorschew A, Kesgin F, Bellmann-Strobl J, Flachenecker P, Schiffmann I, Rosenthal F Health Qual Life Outcomes. 2023; 21(1):110.

PMID: 37814258 PMC: 10563229. DOI: 10.1186/s12955-023-02190-2.


Responsiveness of Persian 12-Item multiple sclerosis walking scale: a replication study.

Naghdi S, Nakhostin Ansari N, Haghparast A, Nakhostin-Ansari A, Khalifeloo M, Biglar M BMC Res Notes. 2023; 16(1):45.

PMID: 37016445 PMC: 10071465. DOI: 10.1186/s13104-023-06316-z.


Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder.

Kim W, Park E, Hyun J, Huh S, Park N, Jang H J Clin Neurol. 2020; 16(2):270-276.

PMID: 32319244 PMC: 7174128. DOI: 10.3988/jcn.2020.16.2.270.


Effect of patients' expectations on clinical response to fampridine treatment.

Ladeira F, Mendonca M, Caetano A, Salavisa M, Delgado H, Correia A Neurol Sci. 2018; 40(1):175-180.

PMID: 30374581 DOI: 10.1007/s10072-018-3613-x.


Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking Scale.

Dib H, Tamam Y, Terzi M, Hobart J Mult Scler J Exp Transl Clin. 2017; 3(3):2055217317728740.

PMID: 28975038 PMC: 5613845. DOI: 10.1177/2055217317728740.